The global dermatological drug market is projected to grow at a CAGR of 5.50% to reach US$42.399 billion by 2024, from US$30.742 billion in 2018. The demand for dermatological drugs is rising due to growing skin diseases, rising disposable and out-of-pocket incomes and growing awareness regarding skin health. Common medications for skin indications include antibacterial, anthralin, antifungals, retinoids etc.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global dermatological drug value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global dermatological drug market.
Major industry players profiled as part of the report are AbbVie Inc., Curatio Healthcare, Sienna Biopharmaceuticals, Glenmark and NovaBay Pharmaceuticals, Inc. among others.
The global dermatological drug market has been analyzed through following segments:
By Route of Administration
By End User
Hospitals and Clinics
Middle East and Africa
Frequently Asked Questions (FAQs)
Q1. What will be the dermatological drug market size by 2024?
A1. The global dermatological drug market is projected to reach a total market size of US$42.399 billion by 2024.
Q2. What are the growth prospects for dermatological drug market?
A2. The dermatological drug market is projected to grow at a CAGR of 5.50% during the forecast period.
Q3. What is the size of global dermatological drug market?
A3. Dermatological Drug market was valued at US$30.742 billion in 2018.
Q4. What factors are anticipated to drive the dermatological drug market growth?
A4. The demand for dermatological drugs is rising due to growing skin diseases, rising disposable and out-of-pocket incomes and growing awareness regarding skin health.
Q5. Who are the major players in the global dermatological drug market?
A5. Major industry players profiled as part of the dermatological drug market report are AbbVie Inc., Curatio Healthcare, Sienna Biopharmaceuticals, Glenmark, and NovaBay Pharmaceuticals, Inc. among others.